Table 1.

Study population characteristics

Characteristics	No (%) of participants*
Total No	83 057
Positive for SARS-CoV-2	7973 (9.6)
Age (years):
Mean (SD)	43.97 (16.89)
18-39	37 864 (45.6)
40-59	28 186 (33.9)
≥60	17 007 (20.5)
Sex:
Women	43 554 (52.4)
Men	39 503 (47.6)
Socioeconomic status (levels 1-20):
Mean (SD)	9.69 (3.60)
Missing (%)	8304 (11.11)
Demographic group:
With Arab ancestry	11 771 (14.2)
General population	62 927 (75.8)
Jewish ultra-orthodox	8359 (10.1)
Median No of days elapsed (IQR):
Since second dose of vaccine	164 (138-185)
Between first and second dose of vaccine	21 (21-21)
Comorbid conditions
Diabetes mellitus	8937 (10.8)
Hypertension	16 449 (19.8)
Asthma	7466 (9.0)
Chronic obstructive pulmonary disease	3346 (4.0)
Ischaemic heart disease	3955 (4.8)
Solid tumour	4104 (4.9)
Chronic kidney disease	1486 (1.8)

SD=standard deviation; IQR=interquartile range.

^*Unless stated otherwise.